Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults
Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults
The objective of this study is to investigate the effect of Lactobacillus Delbruckii lactis
 (DN111244) fermented milk consumption on relative change of plasma LDL-cholesterol
 concentration in hypercholesterolaemic adults after 8 weeks of product consumption versus
 control product.
Inclusion Criteria:

 -  male and female aged 18-75 years;

 -  BMI between 19 and 30 kg/m2,

 -  LDL-cholesterol plasma level between 130 mg/dL to 190 mg/dL (bounds included) with or
 without statin monotherapy,

 -  stabilized hypercholesterolemia (since more than 3 months),

 -  accepting to follow the dietary recommendations advisable for hypercholesterolemic
 patient (NCEP-ATP III guidelines),

 -  used to consume dairy products,

 -  for female: effective contraceptive methods used,

 -  agreeing to a written informed consent

 Exclusion Criteria:

 -  plasma triglycerides (TG) levels > 350 mg/dL (4 mmol//L),

 -  any cardiovascular event (infarction, angina, surgical or endocoronary intervention,
 stroke, peripheral arteriosclerosis, etc) in the last 6 months,

 -  known allergy or hypersensitivity to milk proteins,

 -  systemic treatment or topical treatment likely to interfere with evaluation of the
 study parameters,

 -  subject currently involved in a clinical trial or in an exclusion period following
 participation in another clinical tria,

 -  subject in a situation which in the investigator's opinion could interfere with
 optimal participation in the present study or could constitute a special risk for the
 subject,

 -  diabetic subjects (type I and type II),

 -  any kind of disease likely to interfere with the evaluation of efficiency or safety of
 the product,

 -  for female subject: pregnancy, breast feeding or intention to become pregnant during
 the study,

 -  for female subject: subject likely to change her contraceptive method during the
 study,

 -  active heavy cigarette smokers (reported more than 20 cigarettes / day),

 -  subjects who are actively participating in a weight loss program or have participated
 in a weight loss program in the three months prior to screening for the study